ArticleInternational journal of nanomedicine2020
Biosynthesis of Silver Nanoparticles Using Culture Supernatant of
Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 68 citations in OpenAlex.
- Silver nanoparticles in biomedicine: green synthesis, precision theranostics, and future clinical translation.Folia microbiologica · 2026Review
- Biosynthesized Silver Selenide Nanoparticles fromMicroorganisms · 2025Article
- Exploring the novel paper wasp (Parapolybia escalerae) honey for green synthesis of silver nanoparticles with antibacterial properties.Scientific reports · 2025Article
- Salicylic Acid-Mediated Silver Nanoparticle Green Synthesis: Characterization, Enhanced Antimicrobial, and Antibiofilm Efficacy.Pharmaceutics · 2025Article
- Silver nanoparticles as next-generation antimicrobial agents: mechanisms, challenges, and innovations against multidrug-resistant bacteria.Frontiers in cellular and infection microbiology · 2025Review
- Synthesis of Silver Nanoparticles and Gold Nanoparticles Used as Biosensors for the Detection of Human Serum Albumin-Diagnosed Kidney Disease.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Anticandidal Activity of a Siderophore from Marine EndophyteAntibiotics (Basel, Switzerland) · 2024Article
- Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics.Frontiers in microbiology · 2024Review
- Optimization of the biosynthesis of silver nanoparticles using bacterial extracts and their antimicrobial potential.Biotechnology reports (Amsterdam, Netherlands) · 2023Article
- Preparation and characterization of spiked gold nanobipyramids and its antibacterial effect on methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus.Journal, genetic engineering & biotechnology · 2023Article
- Biogenic Silver Nanoparticles Produced by Soil Rare Actinomycetes and Their Significant Effect onMicroorganisms · 2023Article
- Antimicrobial Activity of Green Synthesized Silver Nanoparticles Using Waste Leaves ofMicroorganisms · 2023Article
- Biosynthesis of Metal and Metal Oxide Nanoparticles Using Microbial Cultures: Mechanisms, Antimicrobial Activity and Applications to Cultural Heritage.Microorganisms · 2023Review
- Biosynthesis of Silver Nanoparticles Using the Biofilm Supernatant ofInternational journal of nanomedicine · 2023Article
- Extracellular biosynthesis, OVAT/statistical optimization, and characterization of silver nanoparticles (AgNPs) using Leclercia adecarboxylata THHM and its antimicrobial activity.Microbial cell factories · 2022Article
- Synthesis, Characterization and Biomedical Application of Silver Nanoparticles.Materials (Basel, Switzerland) · 2022Review
- Bionanofactories for Green Synthesis of Silver Nanoparticles: Toward Antimicrobial Applications.International journal of molecular sciences · 2021Review
- Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?Nanomaterials (Basel, Switzerland) · 2021Review
- Microbe-Mediated Biosynthesis of Nanoparticles: Applications and Future Prospects.Biomolecules · 2021Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn this study, silver nanoparticles (AgNPs) were biosynthesized using culture supernatant of strain
methodsThe strain
resultsThe UV-Vis spectral analysis revealed absorption maxima at 450 nm which confirmed the formation of AgNPs. The FTIR analysis suggested the involvement of various supernatant biomolecules, as reducing and capping agents in the synthesis of AgNPs. The XRD and EDX analysis confirmed the crystalline and metallic nature of AgNPs, respectively. The TEM and SEM analysis showed nanoparticles were spherical with an average size of 38 nm. The biosynthesized AgNPs inhibited the growth and formed a clear zone of inhibition (ZOI) against tested Gram-negative strains. The MIC and MBC were determined as 8-16 µg/mL and 32 µg/mL, respectively. Further, electron microscopy analysis of treated cells showed that AgNPs can damage the outer membrane, release of cytoplasmic contents, and alter the normal morphology of Gram-negative bacteria, leading to cell death. The hemolytic assay indicated that the biosynthesized AgNPs were biocompatible at low dose concentrations.
conclusionThis study demonstrates an eco-friendly process for extracellular synthesis of AgNPs using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.